antifungal agent

(redirected from Flucytosine)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for antifungal agent

References in periodicals archive ?
Subsequently, after proper diagnosis intravenous amphotericin B and oral flucytosine was started and after 4 months of prolonged therapy, he made an uneventful recovery.{Figure 1}{Figure 2}{Figure 3}{Figure 4}{Figure 5}
Even though flucytosine is a simple, off-patent agent that has been in clinical use for over five decades, [7] there are two major barriers to access in SA.
In the absence of flucytosine, the expert panel advocates that Southern African patients should be treated with the following induction therapy for the first two weeks: amphotericin B deoxycholate (1 mg/kg/day intravenous (IV) administration) plus fluconazole (800 mg per os (PO) daily).
From the review of the literature in this current research review paper, boric acid in vaginal suppositories twice per day for two weeks has an optimal outcome and rates are comparable to nystatin, flucytosine, and the azoles; and the recurrence rates are small in most of the studies.
According to the company, Flucytosine Capsules are the first approved generic version of Valeant Pharmaceuticals International's Ancobon Capsules.
the need for new and improved antifungal agents marches on." (55) This is partially because the commonly used pharmaceutical antifungal agents are not always effective: (56,57) "Emerging cases of drug resistance to currently available drugs has limited the spectrum of currently available antifungal agents." (58) "Drugs for systemic antifungal treatments include amphotercin B, various azole derivatives, and flucytosine." (5)
In vitro susceptibility data suggest that ketoconazole is active against this fungus, but that fluconazole and flucytosine are inactive.
In vitro susceptibility data suggest that ketoconazole is active against this fungus but that fluconazole and flucytosine are inactive.
[Vfend] ketoconazole $3.15 (200 mg) 200-400 mg/day [Nizoral] [$4.30] griseofulvin $2.22 (500 mg) 500-1,000 mg/day [Grifulvin V] [$1.81] [Gris-Peg] [$2.76] flucytosine [$16.16 (250 mg q.i.d.)] 250-500 mg q.i.d.
(3-9) Infection due to P boydii is often resistant to common antimycotic drugs, such as amphotericin B and flucytosine. (1) Failure to recognize this fungus as an aggressive opportunistic infection because of the morphologic resemblance of P boydii to other fungi, such as Aspergillus species and Fusarium species, and the time required for culture and identification of the organism may delay appropriate therapy and result in a fatal outcome.
(4) Minimum inhibitory concentrations (MIC) were read as the lowest drug concentrations that produced either a 50% (for flucytosine, voriconazole, itraconazole, fluconazole, micafungin, posaconazole, anidulafungin, and caspofungin) or a 100% (amphotericin B) inhibition of growth compared to that of the control wells without antifungal drugs (Table 1).
Despite antifungal treatment with amphotericin B and flucytosine, fungal meningitis, cerebral arterial vasospasm at the Willis polygon, and hydrocephalus developed.
The systemic antifungal classes currently available are polyenes, triazoles, echinocandins, and flucytosine. For all of them, the PK/PD indices have been determined both in vitro and in vivo, (17-21) and the results confirmed by clinical studies (Table 1), demonstrating that dose optimization to attain PD targets leads to higher clinical efficacy (22,23) Due to limited availability of flucytosine in developing countries, the present review will focus on the PD of polyenes, triazoles, and echinocandins.
WHO recommends treating immunocompromised patients with CM with a combination of amphotericin B and flucytosine for two weeks followed by 8-10 weeks of fluconazole (400-800 mg daily) and then fluconazole (200 mg daily) for an additional 6-12 months [14].
In this test, seven antifungal agents were used, including amphotericin B (4ug/ml), nystatine (200 units/ml), flucytosine (35ug/ml), econazole (16ug/ml), ketoconazole (16ug/ml), miconazole (16ug/ml) and fluconazole (16ug/ml).